A Genome-Wide Screening in Saccharomyces cerevisiae for Genes That Confer Resistance to the Anticancer Agent Cisplatin
- 1 March 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 269 (3), 767-774
- https://doi.org/10.1006/bbrc.2000.2361
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)FEBS Letters, 1999
- Involvement of the DNA mismatch repair system in antineoplastic drug resistanceZeitschrift für Krebsforschung und Klinische Onkologie, 1999
- Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and CarboplatinJournal of Clinical Oncology, 1999
- ADVANCED TESTICULAR CANCER: UPDATE FOR UROLOGISTSJournal of Urology, 1998
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- Cisplatin resistance and DNA repairCancer Treatment Reviews, 1997
- Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?Seminars in Cancer Biology, 1997
- The molecular basis of cisplatin sensitivity/resistanceEuropean Journal Of Cancer, 1994
- Cellular accumulation of the anticancer agent cisplatin: A reviewBritish Journal of Cancer, 1993
- Treatment of testicular cancer: a new and improved model.Journal of Clinical Oncology, 1990